Drugs / ONO-4641
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01226745 | Oct 2010 → Jan 2015 | multiple sclerosis | EMD Serono | Terminated | No outcome recorded |
| Phase 2 | NCT01081782 | Mar 2010 → Dec 2011 | multiple sclerosis | Ono Pharma USA Inc | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-4641 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01226745 ↗ |